YDES (YDES) revenue breakdown
By product, Medical and related products is the largest at 47% of fiscal 2025 revenue, growing 38% a year over 2 years.
Revenue by product
Fiscal years, as YDES reports them in its 10-K filings; fiscal 2025 total $596,817.
| Products | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|
| Medical and related products | $146,850 | $292,858 | $280,774 | 47% |
| Drugs | $141,947 | $143,633 | $223,425 | 37% |
| Beauty products | — | — | $49,911 | 8% |
| Contact lenses | — | — | $35,000 | 6% |
| Nutritional products | $9,540 | $41,772 | $5,234 | 1% |
| Supplements | $51,794 | $32,097 | $2,473 | 0% |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for YDES.
Open YDES in InvestinglyQuestions
Where does YDES make its money?
In fiscal 2025, by product: Medical and related products $280,774, Drugs $223,425, Beauty products $49,911, Contact lenses $35,000, Nutritional products $5,234.
From YDES's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.